The Hemoglobin Testing Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Hemoglobin Testing Market:
https://www.thebusinessresearchcompany.com/report/hemoglobin-testing-global-market-report
According to The Business Research Company’s Hemoglobin Testing Global Market Report 2024, The hemoglobin testing market size has grown strongly in recent years. It will grow from $2.54 billion in 2023 to $2.71 billion in 2024 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to prevalence of anemia, maternal health initiatives, blood donation programs, chronic diseases management, global health awareness campaigns.
The hemoglobin testing market size is expected to see strong growth in the next few years. It will grow to $3.65 billion in 2028 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to rising healthcare investments, integration with chronic disease management, point-of-care testing expansion, increasing focus on preventive healthcare, global health pandemics preparedness. Major trends in the forecast period include telemedicine and remote monitoring, technological advancements, home-based testing kits, integration with electronic health records (ehr), focus on non-invasive methods.
A rising prevalence of chronic disorders such as diabetes is expected to propel the growth of hemoglobin testing. Diabetes is a chronic condition that arises when the pancreas does not create enough insulin or when the body does not utilize the insulin that is produced adequately. Hemoglobin A1c tests (HbA1c) are used to monitor glucose levels in diabetic patients and are recommended by the American Diabetes Association as a viable option for fasting blood glucose for diabetes diagnosis. For instance, in November 2022, according to the US Census Bureau, a US-based department of the Federal Statistical System, more than 34 million Americans have diabetes, with an additional 88 million at risk. Additionally, in December 2021, according to the IDF Diabetes Atlas 10th edition published by the International Diabetes Federation, a Belgium-based global diabetes community, diabetes afflicted 536,000 individuals in 2021, and by 2030, it is predicted to climb to 642,800. By 2045, it will reach 783,700 individuals globally. Therefore, the rising prevalence of chronic disorders such as anemia and diabetes will drive the hemoglobin a1c testing devices market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=10059&type=smp
The hemoglobin testing market covered in this report is segmented –
1) By Product: Reagents And Consumables, Equipment
2) By Technology: Chromatography, Immunoassay, Spectrophotometry, Other Technologies
3) By End User: Hospitals, Clinics, Laboratories, Home Care Settings, Blood Banks, Other End Users
Major companies operating in the hemoglobin testing market are developing innovative products such as liquid chromatography analyzers to meet larger customer bases, more sales, and increase revenue. Liquid chromatography analyzers are analytical instruments designed for the separation, identification, and quantification of components in a liquid mixture. For instance, in June 2021, Trivitron Healthcare, an India-based medical technology company, launched NANO H5 and NANO H110, two high-performance liquid chromatography analyzers designed for the rapid detection of HbA1c in under 3 minutes. The distinctive feature of NANO H5, a compact and automated HPLC analyzer, lies in its utilization of ion exchange liquid chromatography for the rapid and quantitative determination of glycated hemoglobin (HbA1c) in human whole blood, boasting a swift processing time of 130 seconds that expedites laboratory turnaround time (TAT). On the other hand, NANO H110, another compact and automated HPLC analyzer, stands out with its dual test mode catering to both HbA1c testing and Hb variant detection. It incorporates advanced features such as a barcode scanner and cap piercing, coupled with a substantial sample loading capacity of 110 samples simultaneously, making it particularly well-suited for laboratories with medium to large workloads.
The hemoglobin testing market report table of contents includes:
1. Executive Summary
2. Hemoglobin Testing Market Characteristics
3. Hemoglobin Testing Market Trends And Strategies
4. Hemoglobin Testing Market – Macro Economic Scenario
5. Global Hemoglobin Testing Market Size and Growth
………………..
31. Global Hemoglobin Testing Market Competitive Benchmarking
32. Global Hemoglobin Testing Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Hemoglobin Testing Market
34. Hemoglobin Testing Market Future Outlook and Potential Analysis
35. Appendix
Read Related Topics:
https://topprnews.com/benzoic-acid-global-market-2024-by-trends-key-drivers-top-manufacturers-opportunities-forecast-to-2033-emerald-kalama-llc-ig-petrochemicals-ltd-merck-kgaa/
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
